Post-approval studies (Phase 4)Study completedNCT00431444
What this trial is testing
Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density
Who this might be right for
Osteoporosis
Novartis 110